Fertility Treatments & Assisted Reproductive Technologies
Explore evidence-based fertility solutions — IVF, ICSI, IUI, fertility preservation, minimal-access reproductive surgeries, and comprehensive antenatal care delivered across 5 state-of-the-art centres in Delhi NCR & Meerut.
IVF and ICSI
How your eggs, your partner's sperm, and your embryos are handled — and why the details decide the outcome
Most fertility treatment eventually comes down to IVF or ICSI. What varies between clinics is not the procedure name — it is the stimulation dose chosen for your specific hormone picture, the quality of the embryology lab, and how decisions are made along the way.
IVF retrieves eggs from your ovaries, fertilises them with prepared sperm in the lab, and places the resulting embryo into your uterus. The stimulation dose used to grow your eggs is calculated from your AMH (the hormone that reflects how many eggs you have left) and your antral follicle count — not a standard protocol applied to everyone who walks through the door.
- Stimulation dose calculated from your AMH, antral follicle count, and what your ovaries did in any previous cycle
- Eggs retrieved under light sedation through a fine ultrasound-guided needle — no incision
- Embryos grown in low-oxygen incubators that replicate conditions inside a fallopian tube
- Progesterone support after retrieval calibrated to your lining thickness and hormone levels
- Protocol decisions follow ESHRE and ASRM international guidelines
In ICSI, one selected sperm is injected directly into a mature egg instead of leaving fertilisation to happen on its own. It is used when sperm numbers or movement are severely reduced, when a previous IVF cycle produced little or no fertilisation, or when sperm has been retrieved surgically.
- One morphologically selected sperm injected into each mature egg under high magnification
- Standard approach for severe low sperm count, very poor motility, or prior fertilisation failure
- Used in every cycle where sperm is retrieved by TESA, PESA, or Micro-TESE
- Achieves fertilisation in 70–80% of mature eggs injected
- Prevents total fertilisation failure when sperm quality is uncertain
Good embryos not transferred in the fresh cycle are frozen by vitrification — cooling at minus 20,000 degrees per minute, which prevents ice crystals from damaging the cells. Frozen transfers often work better than fresh ones because your uterus has recovered from stimulation and is in a more receptive state.
- Vitrification achieves post-thaw embryo survival above 95%
- Freeze-all strategy used when OHSS (over-stimulation) risk is elevated — no embryo transferred fresh
- Frozen transfers done in natural, modified natural, or hormone-replacement cycles
- Embryos stored in liquid nitrogen at -196 degrees Celsius under continuous sensor monitoring
- Staged single embryo transfers reduce twin pregnancy risk without reducing cumulative success
Embryos transferred at Day 3 have not yet gone through genomic activation — the process that filters out embryos with errors that would stop development. Growing to Day 5 (blastocyst stage) lets that natural selection happen in the lab rather than in your uterus, and gives the embryologist a clearer picture of which embryo has the best chance.
- Day 5 blastocysts have higher implantation rates per transfer than Day 3 embryos
- Embryos that arrest before Day 5 are identified early — avoiding a transfer that would not have worked
- Single embryo transfer becomes a more reliable choice at blastocyst stage
- Sequential culture media formulation matches the embryo's changing metabolic needs each day
- Blastocyst stage required for trophectoderm biopsy when PGT-A or PGT-M genetic testing is planned
When your own eggs cannot be used — because your egg supply has run out early, your AMH is at or near zero, or previous cycles produced no viable embryos — donor egg IVF gives you the highest chance of pregnancy available in reproductive medicine. All donor cycles in India run through government-registered ART Banks under the ART (Regulation) Act, 2021.
- All donor eggs sourced exclusively from registered ART Banks — no direct donor recruitment
- Donors screened for infectious diseases, chromosomal abnormalities, and thalassaemia carrier status
- Physical matching for blood group, height, skin tone, and ethnic background
- Strict anonymity maintained under Indian law — you will not meet the donor
- Psychological counselling for you and your partner before the process begins
Sperm can be frozen in liquid nitrogen and stored for future IVF, ICSI, or IUI cycles. This is done before cancer treatment begins, when your partner cannot be present on egg retrieval day, as a backup before any IVF cycle, or as part of a longer-term fertility preservation plan.
- Semen evaluated before freezing and tested after thawing to confirm motility is preserved
- Multiple aliquots stored in separate sealed straws — different portions used across future cycles
- Post-thaw sperm suitable for IUI, standard IVF, or ICSI depending on quality
- Emergency banking for men facing chemotherapy or pelvic radiotherapy arranged urgently
- Annual storage contracts with transparent audit and renewal processes
When no sperm appears in the ejaculate, sperm can be retrieved directly from the epididymis or testis through a minor surgical procedure. Combined with ICSI, this allows men with a physical blockage or with reduced sperm production to have biological children.
- PESA: percutaneous epididymal aspiration — for blockage-related absence of sperm (post-vasectomy, absent vas deferens)
- TESA: testicular aspiration under local anaesthesia — fine-needle biopsy
- Micro-TESE: microsurgical dissection under operating microscope — for non-obstructive absence of sperm where production is focal
- An embryologist confirms sperm presence in real time during the procedure
- Sperm used immediately for ICSI or frozen for a future cycle
Before implanting, an embryo must break free of its outer shell (the zona pellucida). A precise laser creates a small opening to help. This is not done for every patient — it is applied in specific situations where the shell is unusually thick or where good-quality embryos have failed to implant before.
- Indicated for women 37 and above, or where zona thickness exceeds 15 micrometres
- Used after frozen-thawed transfers, where cryopreservation can harden the outer shell
- Applied selectively in recurrent implantation failure with morphologically good embryos
- Computer-guided laser ensures no thermal injury to the embryo cells
- Whether it applies to your situation is discussed before it is scheduled
A small cell sample is taken from the outer layer of a Day 5 embryo and tested for chromosomal abnormalities (PGT-A) or specific inherited gene mutations (PGT-M). Only chromosomally normal embryos are transferred. Sex-selection is illegal in India and strictly prohibited under the PCPNDT Act 1994 and ART Act 2021 — PGT is used exclusively for medical screening.
- PGT-A screens for extra or missing chromosomes — the most common cause of IVF failure and early pregnancy loss
- PGT-M screens for specific inherited conditions: Thalassaemia, Sickle Cell disease, Cystic Fibrosis, and others
- Next-generation sequencing performed on trophectoderm cells — the cells that form the placenta, not the embryo itself
- Indicated for recurrent pregnancy loss, advanced maternal age, and couples carrying a known inherited condition
- Reduces wasted transfers by selecting only chromosomally normal embryos
Female Infertility
Finding the reason first — then choosing the least treatment needed
An accurate diagnosis before any treatment is what prevents unnecessary cycles. For some couples, the reason conception has not happened changes the treatment plan entirely. For others, it confirms that IVF is the right first step.
A fertility investigation looks at four things: your egg supply, whether you are releasing an egg each month, whether your tubes are open, and whether the inside of your uterus is normal. Getting these four answers accurately is what points the treatment in the right direction.
- Egg supply: AMH blood test and antral follicle count by ultrasound
- Hormone baseline on Day 2–3: FSH, LH, Estradiol, TSH, and Prolactin
- Tube assessment: HSG or SSG — a dye test to check whether tubes are open
- 3D pelvic ultrasound to assess uterine shape and lining
- Hysteroscopy or laparoscopy if a structural problem is suspected on scan
IUI concentrates your partner's best-moving sperm in the lab and places them directly into your uterus at the moment of ovulation. It bypasses the cervix, shortens the distance sperm travels, and is the least invasive assisted conception option. It takes five minutes and requires no anaesthesia.
- Appropriate for mild male factor, unexplained infertility, cervical factors, or ovulatory problems
- Requires at least one confirmed open fallopian tube before starting
- Mild stimulation with Letrozole or low-dose FSH injections, tracked by serial ultrasound
- Double-density gradient preparation concentrates the best-moving sperm
- Typically assessed over 3–4 cycles before recommending IVF if pregnancy has not occurred
Egg freezing preserves your eggs at their current age for future use. The eggs go through the same retrieval process as IVF, then are frozen by vitrification. You can use them years later without the eggs having aged in the interim.
- Stimulation and retrieval: a 10–14 day process following standard IVF protocols
- Vitrification achieves post-thaw egg survival above 90%
- For women facing cancer treatment: egg freezing can be coordinated within a 10–14 day window before chemotherapy begins
- Elective preservation: best outcomes when eggs are frozen before age 35
- Transparent counselling on how many eggs give a reasonable chance of future live birth, based on your age
PCOS (Polycystic Ovary Syndrome) is the most common cause of irregular or absent ovulation. The approach here is sequential: metabolic optimisation first, then ovulation induction medication, then IVF only if simpler steps have not worked. The International PCOS Clinical Guidelines are the benchmark.
- Metabolic management: Myo-inositol, Metformin, and nutritional guidance where insulin resistance is present
- First-line ovulation medication: Letrozole rather than Clomiphene, per current guidelines
- Serial ultrasound monitoring to prevent more than two follicles developing — reducing twin risk
- Laparoscopic Ovarian Drilling reserved for medication-resistant cases after adequate trials
- For IVF: GnRH antagonist protocol with agonist trigger eliminates OHSS risk in PCOS patients
A pre-conception review finds what needs to be addressed before pregnancy begins — not after. Nutritional gaps, thyroid status, immunity to certain infections, and inherited conditions that could affect your baby are all checked and managed before any conception attempt.
- Thalassaemia and blood disorder carrier screening for both partners — particularly important before IVF
- Folic acid 5 mg daily, Vitamin D3, and micronutrient supplementation
- Thyroid optimisation (TSH target below 2.5 µIU/mL) and blood sugar management where indicated
- Rubella and Varicella immunity check — vaccination arranged before conception if immunity is absent
- Psychological support for couples who have been on this path for a long time
Serial ultrasound scans track how your lead follicle grows across a cycle and confirm when it is ready to release an egg. This pins down your fertile window precisely for timed intercourse, IUI, or trigger injection timing — and confirms whether ovulation actually happened.
- Scans begin on Day 8–10 of your cycle
- Lead follicle tracked until it reaches optimal maturity (18–20 mm)
- Lining thickness, morphology, and blood flow assessed at each scan
- Trigger injection given when the follicle is ready — ovulation timed precisely
- Confirms whether ovulation occurred and whether the second half of your cycle is adequately supported
For women who are not releasing eggs regularly, medication stimulates the ovary to develop and release one egg in a controlled way. This applies to WHO Group II irregular cycles, PCOS, and unexplained infertility where your tubes are confirmed open.
- First-choice medication: Letrozole (aromatase inhibitor) — fewer side effects than Clomiphene
- Step-up low-dose FSH or hMG injections for cases not responding to oral medication
- Close ultrasound monitoring throughout to avoid more than two mature follicles
- Trigger injection synchronises ovulation timing for intercourse or IUI
- Progesterone support in the second half of your cycle after confirmed ovulation
Male Infertility
Male factor is involved in nearly half of all cases — and it is almost never a dead end
A difficult semen report is a starting point, not a verdict. Some causes are fully reversible. Others can be bypassed with ICSI and surgical sperm retrieval. The evaluation looks at what is causing the numbers — not just what the numbers are.
A thorough assessment looks at your medical history, hormone levels, physical examination, and semen analysis together. The cause of a low count or poor movement determines whether the treatment is medication, surgery, or direct assisted conception — and starting with the right answer saves time and cycles.
- Full medical, occupational, and lifestyle history — heat exposure, previous infections, medications
- Physical examination for varicocele (enlarged testicular veins), testicular volume, and vas deferens patency
- Hormone profile: Testosterone, FSH, LH, Prolactin — finds hormonal causes of reduced sperm production
- Scrotal Colour Doppler ultrasound to detect varicocele not palpable on clinical examination
- Coordinated review by andrologist, urologist, and embryology team where ICSI or surgery is involved
Low sperm count, poor motility, and abnormal shape are the three most common male factor problems. Many respond to targeted treatment. When they do not, ICSI bypasses the need for sperm to swim to and penetrate an egg independently.
- Antioxidant and micronutrient therapy: CoQ10, L-Carnitine, Zinc, Lycopene — supported by clinical data
- Hormonal treatment for insufficient pituitary signalling to the testes (hypogonadotropic hypogonadism) using hCG and hMG
- Varicocele repair for Grade II–III varicoceles where semen parameters are significantly affected
- Advanced sperm selection for ICSI: MACS (magnetic-activated cell sorting) and microfluidics
- Clear pathway from medication through IUI to ICSI based on your total motile sperm count
A semen analysis measures the quantity and quality of sperm. The lab here uses the WHO 2021 sixth edition manual — which updated key thresholds from the 2010 version. If your previous report was done elsewhere, it is worth checking whether it used current reference values.
- Standardised 2–5 day abstinence window; private on-site collection suite available
- Macroscopic evaluation: volume, pH, liquefaction time, viscosity
- Computer-assisted and manual microscopic analysis of concentration, total count, and progressive motility
- Strict Kruger morphology assessment of sperm head, midpiece, and tail
- Leukocyte testing and semen culture for infection
Standard semen analysis does not show whether the DNA inside sperm is intact. High DNA fragmentation — damaged strands inside the sperm — is linked to poor embryo development, recurrent pregnancy loss, and unexplained IVF failure, even when the rest of the semen report looks normal.
- Measured by SCSA or Sperm Chromatin Dispersion (SCD) assay
- A DNA Fragmentation Index above 25–30% is clinically significant
- Guides targeted antioxidant treatment and lifestyle changes to reduce oxidative damage
- High fragmentation may direct the decision toward testicular sperm retrieval (TESA), where fragmentation is typically lower
- Recommended for couples with recurrent pregnancy loss or unexplained fertilisation failure in previous IVF
Men with very low counts (below 5 million per mL) or no sperm at all may have a genetic cause. Identifying it matters before surgery — it determines whether an operation is likely to find sperm, and whether a condition could be passed to a child conceived through ICSI.
- Peripheral blood karyotype: detects Klinefelter syndrome (47,XXY) and chromosomal translocations
- Multiplex PCR for Y-chromosome microdeletions across AZFa, AZFb, and AZFc regions
- AZFc deletion: positive prognosis for finding sperm via Micro-TESE
- AZFa and AZFb deletions: associated with complete absence of sperm production — important to establish before surgery
- CFTR gene testing for Congenital Bilateral Absence of the Vas Deferens (CBAVD)
Fertility Surgeries
Keyhole surgery that removes what is in the way — without touching what matters
Blocked tubes, fibroids inside the uterus, polyps, endometriosis, and scar tissue are all treatable surgically. The procedures here use small incisions or no incisions at all, are done as day-care or overnight stays, and are designed to protect your egg supply and uterine lining.
Laparoscopy gives a direct, high-definition view of your pelvis through a keyhole incision. In a single sitting, a surgeon can identify and treat adhesions, ovarian cysts, tubal blockages, and endometriosis — without a large abdominal incision and with a return to normal activity within a week.
- Keyhole incisions of 5–10 mm — less pain and faster recovery than open surgery
- Direct evaluation of fallopian tubes using chromopertubation (blue dye test) to confirm patency
- Tissue-sparing dissection preserving healthy ovarian cortex throughout
- Anti-adhesion agents applied at the end of surgery to reduce the risk of new scar tissue
- Day-care or 24-hour discharge in most cases
Hysteroscopy passes a thin camera through the cervix into the uterine cavity — no incision of any kind. It is the most reliable way to find and treat anything inside the uterus that might prevent an embryo from implanting: polyps, a septum dividing the cavity, submucous fibroids, or scar tissue from previous surgery or infection.
- No incision — the camera enters through the natural cervical passage
- Uterine septum division (septoplasty) to restore a single normal cavity
- Removal of endometrial polyps, submucous fibroids, and retained products
- Scar tissue division (Asherman syndrome) under direct vision
- Improves implantation rates significantly when done before a planned IVF or frozen embryo transfer
A hydrosalpinx is a tube blocked and filled with fluid. That fluid leaks into the uterus and is toxic to embryos. Clipping or removing the affected tube before IVF substantially improves implantation and pregnancy rates — sometimes doubling them.
- Laparoscopic chromopertubation to confirm blockage location and nature under direct vision
- Fimbrioplasty and adhesiolysis for mild distal blockages where the tube can be salvaged
- Laparoscopic salpingectomy or proximal tubal clipping for hydrosalpinx before IVF
- Hysteroscopic tubal cannulation for proximal spasm or mucous plugs — no surgery needed
- Where tubes are irreparably damaged, direct transition to IVF is discussed clearly and honestly
Endometriosis grows tissue like the uterine lining outside the uterus — causing pain, pelvic inflammation, and over time affecting egg quality and tube function. Excision surgery removes the disease completely rather than ablating its surface, restoring the pelvic environment for conception.
- Full excision of Stage I–IV endometriosis lesions rather than surface ablation — lower rate of recurrence
- Ovarian endometrioma (chocolate cyst) removal using stripping technique that limits AMH loss
- Relieves chronic pelvic pain, painful periods, and pain during intercourse
- Restores pelvic anatomy — improves both natural conception rates and IVF outcomes
- A fertility plan starts in the six-month window after surgery, when conditions are optimal
Not all fibroids affect fertility — only those that distort the inside of the uterus or press significantly on the lining need removal before conception. Myomectomy removes the fibroid while leaving the uterus entirely intact.
- Hysteroscopic myomectomy for submucous fibroids (FIGO Type 0, 1, 2) — no incision, through the cervix
- Laparoscopic myomectomy with layer-by-layer suturing to restore uterine muscular integrity
- Post-operative ultrasound to confirm the uterine cavity has healed before conception is attempted
- Safe interval of 3–6 months recommended before embryo transfer or natural conception after laparoscopic myomectomy
Benign ovarian cysts — dermoids, cystadenomas, endometriomas — sometimes require removal. The goal is to remove the cyst without damaging the surrounding ovarian tissue that contains your eggs.
- Pre-operative Doppler ultrasound and tumour markers (CA-125, HE4) to characterise the cyst before surgery
- Atraumatic capsule-stripping dissection preserving the blood supply to healthy ovarian tissue
- Endo-bag retrieval prevents cyst contents spilling into the pelvic cavity
- Precise bipolar haemostasis minimises thermal damage to adjacent follicle pool
- All removed tissue sent for histopathological analysis as standard
Laparoscopic Ovarian Drilling is a surgical option for women with PCOS whose ovaries have not responded to Letrozole or injections after fair trials. Small controlled punctures to the ovarian surface reduce excess androgen production, which is what is preventing regular ovulation — without medication and without twin pregnancy risk.
- 4–6 precise thermal micro-punctures per ovary — calibrated to minimise premature ovarian decline risk
- Reduces intra-ovarian androgen and LH levels, restoring normal hormonal feedback
- Triggers spontaneous single-egg ovulation cycles in subsequent months
- Rapid day-care procedure under general anaesthesia
- Improves ovarian response to low-dose medication if further stimulation is needed
Pelvic scar tissue from previous surgery, infection, or endometriosis can tether your ovaries and fallopian tubes, preventing the egg from being picked up at ovulation. Laparoscopic adhesiolysis frees these bands under direct vision with precision.
- High-definition laparoscopic view allowing precise division of fibrous scar bands
- Restores anatomical mobility between the tube opening and the ovary
- Hyaluronic acid barrier gel applied after surgery to reduce the risk of adhesion reformation
- Often relieves chronic pelvic discomfort as well as improving fertility
- Improves the safety and ease of egg retrieval in future IVF cycles
Polyps inside the uterus cause local inflammation and physically obstruct the space where an embryo needs to implant. Removing them hysteroscopically takes about 15 minutes, requires no incision, and an IVF or IUI cycle can proceed the following month.
- Removed using miniature scissors or a bipolar resectoscope — no external incision
- Complete base excision to reduce the risk of recurrence
- Vaginoscopic approach avoids cervical dilation trauma in most cases
- All removed tissue sent for histopathological analysis
- Your next embryo transfer or IUI cycle can proceed in the following menstrual cycle
Pregnancy Care
Closer monitoring for pregnancies that have earned it
A pregnancy after IVF, recurrent pregnancy loss, or a previous complicated delivery is not a standard antenatal situation. The care here is structured around identifying problems early, with the same specialists who know your history from before the pregnancy began.
Structured antenatal care covers all three trimesters with the right investigations at the right time. For IVF pregnancies, the early weeks have additional monitoring: the viability scan, progesterone support review, and beta-hCG trends. From there, the schedule follows international obstetric standards.
- Early viability and dating scan at 6–8 weeks; progesterone support adjusted based on scan and hormone levels
- First Trimester Combined Screening at 11–13 weeks: Nuchal Translucency scan and Dual Marker blood test
- NIPT (cell-free fetal DNA testing) for chromosomal screening without invasive procedures
- TIFFA Level-II anatomy scan at 18–20 weeks
- Gestational diabetes screening (oral glucose tolerance test) and preeclampsia Doppler risk stratification
Two or more pregnancy losses have identifiable causes in a significant proportion of couples: clotting disorders, immune system abnormalities, chromosomal issues, or uterine structural problems. Finding and treating the cause before the next pregnancy is what changes the outcome.
- Antiphospholipid syndrome panel: Lupus Anticoagulant, Anticardiolipin antibodies, Anti-β2 Glycoprotein-I
- Inherited clotting disorder screen: Factor V Leiden, Protein C and S deficiency
- Parental karyotyping and 3D uterine anomaly ultrasound
- Low-dose aspirin and Low Molecular Weight Heparin (LMWH) when clotting abnormalities are confirmed
- Fortnightly early pregnancy ultrasound and serial cervical length monitoring
Gestational diabetes, pregnancy-related hypertension, thyroid disorders, age 35 and above, or a previous caesarean scar all require structured, close monitoring throughout. Your care is senior consultant-led from the first booking through the delivery plan — not handed to junior staff at key decision points.
- Senior consultant-led care from first booking through delivery
- Serial fetal growth scans and Colour Doppler of umbilical and middle cerebral artery blood flow
- Multi-specialty coordination with endocrinologists, cardiologists, and neonatologists where needed
- Blood pressure protocols and low-dose aspirin from 12 weeks for preeclampsia prevention
- Structured delivery plan and NICU coordination arranged well in advance
Twin pregnancies from IVF carry higher risks of preterm delivery, growth differences between the babies, and preeclampsia. How you are monitored depends on whether your twins share a placenta — which significantly changes the surveillance schedule.
- Chorionicity (placenta type) confirmed at 11–13 weeks — determines surveillance frequency for the entire pregnancy
- Fortnightly growth scans from 16 weeks for monochorionic twins — monitoring for Twin-to-Twin Transfusion Syndrome (TTTS)
- Cervical length measurement and progesterone support to reduce preterm birth risk
- Enhanced nutritional and iron support for the increased demands of a twin pregnancy
- Delivery timing planned and Level-III NICU coordination confirmed in advance
Advanced ultrasound assesses placental blood flow, amniotic fluid, and fetal wellbeing indicators that a standard scan cannot show. The equipment here is GE Voluson with HD-Live — the highest-resolution fetal imaging platform currently available.
- GE Voluson HD-Live imaging for detailed fetal anatomy survey and structural assessment
- Uterine artery Doppler at 11–14 and 20 weeks: early identification of preeclampsia risk
- Umbilical and Middle Cerebral Artery Doppler to detect fetal growth restriction (FGR)
- Fetal Biophysical Profile: real-time assessment of fetal breathing, movement, tone, and amniotic fluid
- Scan findings discussed with you by the consultant at the same appointment
Vaccines given during pregnancy cross the placenta and protect your newborn in the first months of life, before your baby is old enough to receive its own vaccinations. The timing of each vaccine is specific — the right gestational week matters for maximum protection.
- Tdap (Tetanus, Diphtheria, Pertussis) between 27 and 36 weeks — protects your newborn against whooping cough
- Tetanus toxoid schedule per National Immunization Programme guidelines
- Inactivated Influenza vaccine during seasonal peaks — safe across all trimesters
- Anti-D immunoglobulin at 28 weeks for Rh-negative mothers
- Complete vaccination record maintained and reviewed at every antenatal visit
The Non-Stress Test monitors your baby's heart rate over 20–30 minutes and checks whether it responds to the baby's own movements — a sign the placenta is delivering enough oxygen. It is the standard tool for checking fetal wellbeing in the third trimester, particularly in high-risk pregnancies.
- Routine from 32 weeks; from 28 weeks in gestational diabetes, hypertension, or growth restriction
- 20–30 minute continuous electronic trace of fetal heart rate
- Evaluates baseline rate, beat-to-beat variability, and accelerations in response to movement
- A non-reactive trace is followed immediately by a Biophysical Profile assessment
- Monitoring suites available across all clinic locations
Gynaecology
Women's health beyond fertility — from routine screening to complex pelvic conditions
Not every gynaecological concern is about getting pregnant. Heavy periods, irregular cycles, pelvic pain, cervical screening, bladder control, and contraception are all managed here — by specialists who treat these conditions every day and have surgical options when medication is not enough.
A gynaecology consultation covers the full range of women's health outside of fertility: pelvic pain, vaginal infections, hormone imbalances, contraception, menopause, and general reproductive health. Transvaginal ultrasound and laboratory testing are available on-site, so most things are investigated and discussed in the same appointment.
- Comprehensive pelvic, physical, and breast clinical examination
- Immediate transvaginal ultrasound and point-of-care laboratory testing at the same visit
- Hormone Replacement Therapy counselling for menopausal and perimenopausal symptoms
- Management of recurrent vaginal infections, pelvic inflammatory disease, and urinary tract infections
- Transparent discussion of medical versus surgical options before any decision is made
Colposcopy is recommended after an abnormal Pap smear result or a positive high-risk HPV test. It gives a magnified, illuminated view of the cervix to identify any areas of abnormal cell change — and where found, a small targeted biopsy confirms the diagnosis. The procedure takes about 15 minutes and is done as an outpatient.
- Dilute acetic acid and Lugol's iodine applied to highlight abnormal (dysplastic) epithelium
- Targeted punch biopsies of suspicious areas under optical magnification
- Results typically available within 5–7 working days
- Immediate LEEP (Loop Electrosurgical Excision Procedure) for confirmed high-grade CIN-2/3 changes
- Structured follow-up after treatment to confirm clearance
Heavy bleeding, very irregular cycles, or period pain that disrupts your daily life have identifiable causes — structural (polyps, fibroids, adenomyosis) or hormonal — and most respond well to treatment once the cause is established. The FIGO PALM-COEIN classification guides the investigation here.
- High-resolution 3D pelvic ultrasound and endometrial thickness assessment
- Endocrine and haematological workup: Thyroid, Prolactin, coagulation panel
- Hysteroscopy with endometrial sampling for women over 40 or with persistent irregular bleeding
- Medical options: Tranexamic acid, combined oral contraceptives, progestins, Mirena hormonal IUS
- Surgical options available when medication is insufficient or contraindicated
Cervical cancer is one of the most preventable cancers. A Liquid-Based Cytology sample combined with an HPV DNA co-test is currently the most sensitive screening method available — detecting high-risk HPV strains and early cell changes before they develop further.
- Recommended for all women between 21 and 65, per international screening guidelines
- Liquid-Based Cytology (LBC) provides superior cell preservation over conventional smears
- Co-testing for oncogenic HPV strains including HPV 16, 18, 31, 33, 45, 52, and 58
- 2-minute outpatient sample collection with same-day completion
- Direct triage to colposcopy and clinical management if any abnormality is detected
Stress urinary incontinence (leaking when you cough, sneeze, or exercise) and urgency incontinence (sudden strong urge to urinate) are common after childbirth and in menopause — and both are treatable. Treatment starts conservatively and escalates only when needed.
- Clinical examination, bladder diary review, and post-void residual ultrasound to confirm the type of incontinence
- Pelvic floor muscle training (Kegel rehabilitation) and biofeedback — first-line for stress incontinence
- Antimuscarinic and Beta-3 agonist medication for urgency incontinence (Overactive Bladder)
- Minimally invasive Transobturator Tape or TVT sling for stress incontinence when rehabilitation is not enough
- Pessary management and surgical repair options for pelvic organ prolapse
Confidential, individualised contraception guidance covering all options from fully reversible daily or long-acting methods to permanent surgical options. The right choice depends on your medical history, how long you want to delay pregnancy, and what you prefer — with no pressure in either direction.
- Levonorgestrel-releasing IUS (Mirena or Kyleena): highly effective, reduces period pain and blood loss for 5–8 years
- Copper-T (Cu-IUD): non-hormonal, fully reversible protection for 5–10 years
- Combined oral contraceptive pills, progestin-only pills, and injectable depot formulations
- Emergency contraception consultation and confidential counselling
- Laparoscopic bilateral tubal ligation for permanent family completion
Oncofertility
Preserving your fertility before cancer treatment begins — when the window is ten to fourteen days
Cancer treatment — chemotherapy and radiotherapy — can permanently affect your egg supply. For women who have not yet completed their family, there is usually a window between diagnosis and the start of treatment to retrieve and freeze eggs or embryos. The procedures below are coordinated directly with your oncology team without delaying your cancer treatment by a single day.
Chemotherapy for breast cancer — particularly alkylating agents — can permanently reduce or eliminate your egg supply. Freezing eggs or embryos before chemotherapy begins is the most effective way to protect your fertility. For oestrogen-receptor positive (ER+) cancers, a Letrozole-combined stimulation protocol keeps your oestrogen levels within safe limits throughout.
- Stimulation starts on any day of your cycle — no waiting for the next period (random-start protocols)
- Letrozole-combined protocol for ER+ cancers keeps oestrogen within safe limits throughout stimulation
- Egg or embryo freezing completed within 10–14 days — before chemotherapy begins
- Your treating oncologist is kept in the loop at every step — nothing done without their clearance
- Eggs and embryos stored in the vitrification facility until you are ready to use them
An early-stage cervical cancer diagnosis does not automatically mean losing the uterus. In selected cases, the cancer can be treated while preserving your uterus and the possibility of future pregnancy. This requires careful staging and direct collaboration with your gynaecologic oncologist.
- LLETZ or Cold Knife Cone Biopsy for Stage IA1 lesions — removes the cancer, preserves the uterus
- Radical Trachelectomy for selected Stage IB1 cases: cervix removed, uterus preserved
- Cervical cerclage placed to support future pregnancy after fertility-sparing surgery
- Egg or embryo cryopreservation before treatment if pelvic radiotherapy is anticipated
- 3–6 monthly colposcopic and cytological surveillance maintained after treatment
In young women with Grade 1 Stage IA endometrial cancer or atypical hyperplasia, hormone therapy can hold the disease in remission while you attempt pregnancy — before more definitive surgery. This is closely monitored and time-limited, not an open-ended alternative to surgical treatment.
- MRI staging confirms absence of myometrial invasion and lymph node spread before conservative management begins
- High-dose progestin therapy (Megestrol acetate or Medroxyprogesterone) combined with Levonorgestrel-IUS (Mirena)
- Hysteroscopic biopsy every 3 months to confirm remission is holding
- IVF started promptly upon confirmed remission — timing matters in this window
- Definitive surgical hysterectomy recommended after your family is complete
Borderline ovarian tumours and certain early-stage ovarian tumours in young women can often be managed with fertility-sparing surgery — removing only the affected ovary or cyst, leaving the healthy ovary and uterus intact. Outcomes with fertility-sparing surgery for borderline tumours are excellent.
- Unilateral salpingo-oophorectomy or cystectomy, preserving the contralateral ovary
- Complete surgical staging: peritoneal washings, omentectomy, and peritoneal biopsies
- Post-operative AMH and antral follicle count to establish your baseline for future fertility planning
- Ultrasound and tumour marker surveillance (CA-125, HE4, Inhibin) continues during the conception window
- IVF coordinated with oncology team clearance when you are ready to proceed
Legal Surrogacy
Altruistic surrogacy under the Surrogacy (Regulation) Act 2021 — for couples with a certified medical indication
Legal surrogacy in India is available only to couples with a certified medical reason why the intending mother cannot carry a pregnancy. It involves a close relative as surrogate, your own embryos created in a registered ART laboratory, and a multi-stage approval process through the District Medical Board and State Surrogacy Board. The first step is establishing whether your situation qualifies.
The District Medical Board must certify that the intending mother has a condition making pregnancy medically impossible or life-threatening before surrogacy can proceed. Common certified indications include: absent uterus, severe Asherman syndrome unresponsive to treatment, refractory uterine conditions preventing implantation, or a serious systemic illness where pregnancy carries significant maternal risk.
- Full medical evaluation: uterine assessment, clinical history, and investigation records
- Honest assessment of whether your situation meets the Act's defined medical indications — before any further steps
- Guidance on the District Medical Board certification process and what documentation is required
- Surrogate must be a close relative of the couple, aged 25–35, with at least one child, and may serve as surrogate only once
- Mandatory psychological counselling for you and your partner before the process begins
Under the Surrogacy (Regulation) Act 2021, the embryo must be created using your own eggs and your partner's sperm — donor gametes cannot be used in gestational surrogacy. Those embryos are created through IVF or ICSI in a registered ART laboratory, then transferred to your surrogate via a Frozen Embryo Transfer cycle.
- IVF or ICSI using only the intending couple's own gametes — as required under the Act
- Embryo creation and storage in the clinic's ICMR-registered ART laboratory
- Your surrogate undergoes independent medical and psychological evaluation before she participates
- Frozen Embryo Transfer protocol for the surrogate, with full monitoring and support
- All laboratory and clinical records maintained as required under the ART Act 2021
The legal framework runs in parallel with the clinical process. It includes a surrogacy agreement prepared by your legal counsel, registration with the State Surrogacy Board, and a court order establishing you as your child's legal parents. The clinic manages clinical documentation and ART Act compliance; you need independent legal representation for the agreement and court proceedings.
- District Medical Board certification of medical necessity — the clinic supports clinical documentation preparation
- Surrogacy agreement registered with the State Surrogacy Board by your legal counsel
- Registered ART Clinic certification under the ART Act 2021 maintained and current
- All clinic records maintained and available for legal proceedings
- Post-birth parentage established through court order; you are registered as your child's legal parents
Three adults are making a decision of significant personal and legal consequence. Independent psychological support for you and for the surrogate is required before the process begins — not as a formality, but because informed, voluntary, non-pressured consent from all parties is the ethical and legal foundation of a valid surrogacy arrangement.
- Independent psychological evaluation for the intending couple before the process begins
- Separate psychological assessment for the surrogate — conducted independently from you
- Joint counselling session for all parties to confirm mutual understanding and voluntary consent
- Ongoing emotional support available through the treatment cycle
- Complete confidentiality: your records and the surrogate's records maintained separately at all times
Medical & Regulatory Disclaimer: The clinical information on this page is for patient educational purposes and does not constitute a formal medical diagnosis or treatment plan. Assisted Reproductive Technology (ART) procedures and Surrogacy guidance are conducted strictly in compliance with the Assisted Reproductive Technology (Regulation) Act, 2021, the Surrogacy (Regulation) Act, 2021, and the Pre-Conception and Pre-Natal Diagnostic Techniques (PCPNDT) Act, 1994. Sex-selection in any form is illegal in India and strictly prohibited. Clinical success rates depend on individual medical history, maternal age, ovarian reserve, and specific diagnostic parameters.
Ready to Discuss Your Fertility Journey?
Our senior fertility specialists are available for in-person consultations across all 5 centres in Delhi NCR and Western UP. Book a confidential consultation today.